CONTENTS OF CYTOKINES AND LACTOFERRIN IN ONCOLOGICAL PATIENTS

Abstract. The purpose of present work was to study the peculiarities of cytokine production in patients with malignant tumors, as exemplified by lymphoma and malignant melanoma. Sixty-five patients with malignancies (16 to 74 years old) have been surveyed. Contents of IL-1β, IL-4, TNFα and lactoferr...

Full description

Bibliographic Details
Main Authors: T. I. Dolgikh, E. J. Bychkova, R. H. Galyulin
Format: Article
Language:Russian
Published: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2014-07-01
Series:Медицинская иммунология
Subjects:
Online Access:https://www.mimmun.ru/mimmun/article/view/82
_version_ 1797198155039637504
author T. I. Dolgikh
E. J. Bychkova
R. H. Galyulin
author_facet T. I. Dolgikh
E. J. Bychkova
R. H. Galyulin
author_sort T. I. Dolgikh
collection DOAJ
description Abstract. The purpose of present work was to study the peculiarities of cytokine production in patients with malignant tumors, as exemplified by lymphoma and malignant melanoma. Sixty-five patients with malignancies (16 to 74 years old) have been surveyed. Contents of IL-1β, IL-4, TNFα and lactoferrin were studied in blood serum using enzyme immunoassay technique. The results of study have shown that the patients with melanoma have a significant reduction in IL-1-β and TNFα in blood serum, thus being suggestive for development of deficient immune response. In malignant lymphoma, the patients did also exhibit subnormal values of TNFα and IL-1β (below a threshold level of 5 pg/ml), thus supposing some deficiency in proinflammatory cytokine secretion. An interrelation was shown between the contents of lactoferrin and proinflammatory cytokines. After radical treatment of melanoma, like as in lymphoma patients free of В-symptoms, the lactoferrin contents were within normal limits, whereas in the patients with generalization of malignancy, and in lymphoma patients with В-symptoms, a trend to its increase has been established. Determination of the mentioned parameters in patients with lymphoma and malignant melanoma would provide useful diagnostic and predictive criteria in these clinical conditions.
first_indexed 2024-03-08T05:51:31Z
format Article
id doaj.art-4f465e3c0ea44c868d72aef005abc222
institution Directory Open Access Journal
issn 1563-0625
2313-741X
language Russian
last_indexed 2024-04-24T06:55:21Z
publishDate 2014-07-01
publisher St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
record_format Article
series Медицинская иммунология
spelling doaj.art-4f465e3c0ea44c868d72aef005abc2222024-04-22T13:07:33ZrusSt. Petersburg branch of the Russian Association of Allergologists and Clinical ImmunologistsМедицинская иммунология1563-06252313-741X2014-07-01101677010.15789/1563-0625-2008-1-67-7080CONTENTS OF CYTOKINES AND LACTOFERRIN IN ONCOLOGICAL PATIENTST. I. Dolgikh0E. J. Bychkova1R. H. Galyulin2Омская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитиюОмская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитиюОмский областной клинический онкологический диспансерAbstract. The purpose of present work was to study the peculiarities of cytokine production in patients with malignant tumors, as exemplified by lymphoma and malignant melanoma. Sixty-five patients with malignancies (16 to 74 years old) have been surveyed. Contents of IL-1β, IL-4, TNFα and lactoferrin were studied in blood serum using enzyme immunoassay technique. The results of study have shown that the patients with melanoma have a significant reduction in IL-1-β and TNFα in blood serum, thus being suggestive for development of deficient immune response. In malignant lymphoma, the patients did also exhibit subnormal values of TNFα and IL-1β (below a threshold level of 5 pg/ml), thus supposing some deficiency in proinflammatory cytokine secretion. An interrelation was shown between the contents of lactoferrin and proinflammatory cytokines. After radical treatment of melanoma, like as in lymphoma patients free of В-symptoms, the lactoferrin contents were within normal limits, whereas in the patients with generalization of malignancy, and in lymphoma patients with В-symptoms, a trend to its increase has been established. Determination of the mentioned parameters in patients with lymphoma and malignant melanoma would provide useful diagnostic and predictive criteria in these clinical conditions.https://www.mimmun.ru/mimmun/article/view/82cytokineslactoferrinlymphomamelanomail-1βil-4tnfα
spellingShingle T. I. Dolgikh
E. J. Bychkova
R. H. Galyulin
CONTENTS OF CYTOKINES AND LACTOFERRIN IN ONCOLOGICAL PATIENTS
Медицинская иммунология
cytokines
lactoferrin
lymphoma
melanoma
il-1β
il-4
tnfα
title CONTENTS OF CYTOKINES AND LACTOFERRIN IN ONCOLOGICAL PATIENTS
title_full CONTENTS OF CYTOKINES AND LACTOFERRIN IN ONCOLOGICAL PATIENTS
title_fullStr CONTENTS OF CYTOKINES AND LACTOFERRIN IN ONCOLOGICAL PATIENTS
title_full_unstemmed CONTENTS OF CYTOKINES AND LACTOFERRIN IN ONCOLOGICAL PATIENTS
title_short CONTENTS OF CYTOKINES AND LACTOFERRIN IN ONCOLOGICAL PATIENTS
title_sort contents of cytokines and lactoferrin in oncological patients
topic cytokines
lactoferrin
lymphoma
melanoma
il-1β
il-4
tnfα
url https://www.mimmun.ru/mimmun/article/view/82
work_keys_str_mv AT tidolgikh contentsofcytokinesandlactoferrininoncologicalpatients
AT ejbychkova contentsofcytokinesandlactoferrininoncologicalpatients
AT rhgalyulin contentsofcytokinesandlactoferrininoncologicalpatients